Volume 143, Issue 2, Pages (August 2012)

Slides:

Advertisements

Similar presentations

Volume 145, Issue 1, Pages (July 2013)

Advertisements

Volume 142, Issue 4, Pages (April 2012)

SCOTT SANDERS, CHRISTIAN ELL, S. MICHAEL GRIFFIN, STEPHEN ATTWOOD

Volume 144, Issue 1, Pages e1 (January 2013)

Esophageal Adenocarcinoma

Volume 153, Issue 3, Pages e2 (September 2017)

Volume 148, Issue 2, Pages (February 2015)

The Seattle Protocol Does Not More Reliably Predict the Detection of Cancer at the Time of Esophagectomy Than a Less Intensive Surveillance Protocol

Covering the Cover Gastroenterology

Volume 17, Issue 10, Pages (October 2016)

Five-Year Colon Surveillance After Screening Colonoscopy

Covering the Cover Gastroenterology

Volume 153, Issue 3, Pages e2 (September 2017)

Chris A. Liacouras, MD, Glenn T

Rok Seon Choung, G. Richard Locke, Enrique Rey, Cathy D

Outcomes Among Living Liver Donors

Volume 131, Issue 5, Pages (November 2006)

Volume 152, Issue 5, Pages (April 2017)

Volume 149, Issue 3, Pages e3 (September 2015)

Risk stratification of Barrett's oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study Caryn S Ross-Innes,

Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus Amitabh Chak, Navtej S. Buttar, Nathan.

Volume 148, Issue 7, Pages (June 2015)

Volume 154, Issue 8, Pages e5 (June 2018)

American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease Peter J. Kahrilas, Nicholas.

Volume 142, Issue 2, Pages (February 2012)

Volume 141, Issue 1, Pages (July 2011)

Success as a PhD in Gastroenterology

Volume 154, Issue 4, Pages e1 (March 2018)

Clinical Challenges and Images in GI

Volume 150, Issue 4, Pages (April 2016)

Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis Sonja Kroep,

Volume 155, Issue 6, Pages e4 (December 2018)

Volume 139, Issue 4, Pages e1 (October 2010)

A Cost-Utility Analysis of Ablative Therapy for Barrett's Esophagus

Association Between Length of Barrett's Esophagus and Risk of High-grade Dysplasia or Adenocarcinoma in Patients Without Dysplasia Rajeswari Anaparthy,

Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald

Volume 141, Issue 4, Pages e1 (October 2011)

Volume 143, Issue 3, Pages e1 (September 2012)

Colon Cancer: An Update and Future Directions

Endoscopic Therapy for Barrett's Esophagus

Volume 142, Issue 4, Pages (April 2012)

Volume 154, Issue 5, Pages (April 2018)

Volume 141, Issue 2, Pages (August 2011)

Volume 143, Issue 4, Pages e1 (October 2012)

Volume 145, Issue 2, Pages e2 (August 2013)

The 75th Diamond Anniversary of Gastroenterology: 1943–2018

Volume 392, Issue 10145, Pages (August 2018)

Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma Sachin Wani, Gary Falk, Matthew.

White Paper AGA: Advanced Imaging in Barrett’s Esophagus

Efficacy, Safety, and Long-term Results of Endoscopic Treatment for Early Stage Adenocarcinoma of the Esophagus With Low-risk sm1 Invasion Hendrik Manner,

Volume 146, Issue 3, Pages e1 (March 2014)

Volume 154, Issue 5, Pages e3 (April 2018)

Volume 145, Issue 1, Pages (July 2013)

The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures

The Dawning of a New Editorial Board for Gastroenterology

Baby-Epsilon Steps Toward the Triple Aim

Volume 127, Issue 5, Pages (November 2004)

Risks Associated With Anesthesia Services During Colonoscopy

Janusz A. Jankowski, Dawn Provenzale, Paul Moayyedi Gastroenterology

Volume 155, Issue 6, Pages (December 2018)

Volume 156, Issue 5, Pages e3 (April 2019)

Volume 138, Issue 6, Pages (May 2010)

End-Stage Liver Disease in 2008: Finally a Glass Half Full

Volume 152, Issue 3, Pages e4 (February 2017)

Volume 145, Issue 3, Pages e1 (September 2013)

Prateek Sharma, Gary W. Falk, Allan P

Statin Use Is Associated With a Decreased Risk of Barrett’s Esophagus

Neil Gupta, Joel V. Brill, Marcia Canto, Daniel DeMarco, Brian M

Metformin Does Not Reduce Markers of Cell Proliferation in Esophageal Tissues of Patients With Barrett’s Esophagus Amitabh Chak, Navtej S. Buttar, Nathan.

Volume 144, Issue 1, Pages e1 (January 2013)

Presentation transcript:

Volume 143, Issue 2, Pages 336-346 (August 2012) Consensus Statements for Management of Barrett's Dysplasia and Early-Stage Esophageal Adenocarcinoma, Based on a Delphi Process Cathy Bennett, Nimish Vakil, Jacques Bergman, Rebecca Harrison, Robert Odze, Michael Vieth, Scott Sanders, Laura Gay, Oliver Pech, Gaius Longcroft–Wheaton, Yvonne Romero, John Inadomi, Jan Tack, Douglas A. Corley, Hendrik Manner, Susi Green, David Al Dulaimi, Haythem Ali, Bill Allum, Mark Anderson, Howard Curtis, Gary Falk, M. Brian Fennerty, Grant Fullarton, Kausilia Krishnadath, Stephen J. Meltzer, David Armstrong, Robert Ganz, Gianpaolo Cengia, James J. Going, John Goldblum, Charles Gordon, Heike Grabsch, Chris Haigh, Michio Hongo, David Johnston, Ricky Forbes–Young, Elaine Kay, Philip Kaye, Toni Lerut, Laurence B. Lovat, Lars Lundell, Philip Mairs, Tadakuza Shimoda, Stuart Spechler, Stephen Sontag, Peter Malfertheiner, Iain Murray, Manoj Nanji, David Poller, Krish Ragunath, Jaroslaw Regula, Renzo Cestari, Neil Shepherd, Rajvinder Singh, Hubert J. Stein, Nicholas J. Talley, Jean–Paul Galmiche, Tony C.K. Tham, Peter Watson, Lisa Yerian, Massimo Rugge, Thomas W. Rice, John Hart, Stuart Gittens, David Hewin, Juergen Hochberger, Peter Kahrilas, Sean Preston, Richard Sampliner, Prateek Sharma, Robert Stuart, Kenneth Wang, Irving Waxman, Chris Abley, Duncan Loft, Ian Penman, Nicholas J. Shaheen, Amitabh Chak, Gareth Davies, Lorna Dunn, Yngve Falck–Ytter, John Decaestecker, Pradeep Bhandari, Christian Ell, S. Michael Griffin, Stephen Attwood, Hugh Barr, John Allen, Mark K. Ferguson, Paul Moayyedi, Janusz A.Z. Jankowski Gastroenterology Volume 143, Issue 2, Pages 336-346 (August 2012) DOI: 10.1053/j.gastro.2012.04.032 Copyright © 2012 AGA Institute Terms and Conditions

Figure 1 Proportion of statements achieving consensus with each round of voting. With each round voting improved with iterative changes to the question and supporting evidence. Gastroenterology 2012 143, 336-346DOI: (10.1053/j.gastro.2012.04.032) Copyright © 2012 AGA Institute Terms and Conditions

Figure 2 Management of HGD and/or mucosal cancer (stage T1m) in BE. This consensus has allowed the development of a care pathway for HGD and early adenocarcinoma. Gastroenterology 2012 143, 336-346DOI: (10.1053/j.gastro.2012.04.032) Copyright © 2012 AGA Institute Terms and Conditions